scholarly article | Q13442814 |
P2093 | author name string | Zhiliang Wang | |
Quan Liu | |||
Adrian E Morelli | |||
Adriana T Larregina | |||
Angela Montecalvo | |||
Sherrie J Divito | |||
William J Shufesky | |||
Geza Erdos | |||
Olga A Tkacheva | |||
P2860 | cites work | Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo | Q73100730 |
Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse | Q73153290 | ||
Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival | Q73289641 | ||
The importance of H2 haplotype sharing in the induction of specific unresponsiveness by pretransplant blood transfusions | Q73519039 | ||
Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells | Q73709030 | ||
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival | Q74015557 | ||
Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells | Q74415746 | ||
Linked suppression of skin graft rejection can operate through indirect recognition | Q77620004 | ||
Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance | Q80358513 | ||
Mechanism of action of donor-specific transfusion in inducing tolerance: role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentation | Q80512682 | ||
Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition | Q80752561 | ||
Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells | Q83314647 | ||
Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection | Q93747372 | ||
1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation | Q28370605 | ||
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo | Q30080006 | ||
In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy | Q33424530 | ||
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients | Q35160185 | ||
NK cells promote transplant tolerance by killing donor antigen-presenting cells | Q36228823 | ||
Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo | Q36362829 | ||
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance | Q36376611 | ||
Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells | Q36401207 | ||
Tolerogenic dendritic cells and the quest for transplant tolerance | Q36879029 | ||
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig | Q38363193 | ||
Targeting MHC class I monomers to dendritic cells inhibits the indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term allograft survival. | Q39908894 | ||
Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: a review of efficacy and mechanisms | Q40373804 | ||
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo | Q40752701 | ||
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs | Q41057373 | ||
Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The Netherlands | Q41151625 | ||
Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach | Q41487486 | ||
Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: an efficient way to induce indirect pathway regulation | Q44807533 | ||
Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells | Q46602684 | ||
Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells | Q47384056 | ||
Determination of the IgG2a allotype of CXB recombinant inbred mouse strains by a PCR-based method | Q47916605 | ||
Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. | Q50946765 | ||
Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. | Q51982170 | ||
Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. | Q52547955 | ||
Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. | Q53728143 | ||
The effect of donor strain blood pretreatment on renal allograft rejection in rats | Q53849910 | ||
Planned preimmunization of renal allograft recipients. | Q53933481 | ||
Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection | Q56900558 | ||
"Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig | Q56901846 | ||
Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells | Q56903879 | ||
Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts | Q56906704 | ||
Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells | Q57134111 | ||
Migratory Dendritic Cells Transfer Antigen to a Lymph Node-Resident Dendritic Cell Population for Efficient CTL Priming | Q57227729 | ||
Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation | Q60997248 | ||
Effect of blood transfusions on subsequent kidney transplants | Q69250652 | ||
Genetics of the blood transfusion effect on heart allografts in rats | Q70365718 | ||
Comparison of immune responsiveness in mice after single or multiple donor-specific transfusions | Q72720684 | ||
Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival | Q73045866 | ||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 2694-2705 | |
P577 | publication date | 2010-06-24 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation | |
P478 | volume | 116 |
Q36578322 | Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs |
Q36238593 | Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation |
Q38078105 | Cell therapy using tolerogenic dendritic cells in transplantation |
Q36880118 | Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease |
Q36002657 | Dendritic cell therapies in transplantation revisited: deletion of recipient DCs deters the effect of therapeutic DCs |
Q38059518 | Dendritic cell therapy for Type 1 diabetes suppression |
Q21284774 | Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation |
Q37316849 | Donor bone marrow-derived dendritic cells prolong corneal allograft survival and promote an intragraft immunoregulatory milieu. |
Q37137864 | Donor dendritic cell-derived exosomes promote allograft-targeting immune response |
Q35865098 | Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation |
Q38071421 | Experimental models to investigate the function of dendritic cell subsets: challenges and implications |
Q90529882 | Generation and functional assessment of nonhuman primate regulatory dendritic cells and their therapeutic efficacy in renal transplantation |
Q38682156 | Harnessing the properties of dendritic cells in the pursuit of immunological tolerance |
Q50023625 | High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation |
Q35692028 | Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. |
Q36761540 | Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12 |
Q38955064 | Novel Insights Into the Immunoregulatory Function and Localization of Dendritic Cells |
Q37662989 | Old game, new players: Linking classical theories to new trends in transplant immunology |
Q34379951 | Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells |
Q37040247 | Origin and biology of the allogeneic response |
Q26767458 | Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation |
Q87806866 | Rapid tolerance induction by hematopoietic progenitor cells in the absence of donor-matched lymphoid cells |
Q92303151 | Regulatory dendritic cells for human organ transplantation |
Q50177437 | Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies. |
Q90413377 | Regulatory dendritic cells: profiling, targeting, and therapeutic application |
Q26999875 | Regulatory myeloid cells in transplantation |
Q50993283 | Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells. |
Q30278837 | Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury |
Q56967224 | TIGIT iTregs elicited by human regulatory macrophages control T cell immunity |
Q38256369 | Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles. |
Q52665595 | Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand? |
Q37077325 | Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs. |
Q39013872 | Tolerogenic dendritic cell therapy in organ transplantation |
Q21131223 | Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials |
Q35341379 | Tolerogenic dendritic cells and their role in transplantation. |
Q38339535 | Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus. |
Q38114067 | Transplant tolerance: new insights and strategies for long-term allograft acceptance |
Q47121682 | Update on Dendritic Cell-Induced Immunological and Clinical Tolerance. |
Q55662835 | Upregulation of Heme Oxygenase-1 Endues Immature Dendritic Cells With More Potent and Durable Immunoregulatory Properties and Promotes Engraftment in a Stringent Mouse Cardiac Allotransplant Model. |
Q37869483 | What is the role of antigen-processing mechanisms in autologous tolerogenic dendritic cell therapy in organ transplantation? |